March 19, 2024, 12:23 a.m. | NVIDIA

NVIDIA www.youtube.com

Virtual screening for new medicines is a computationally intractable problem. Existing techniques can only scan billions of compounds and require days on thousands of standard compute nodes. NVIDIA BioNeMo microservices enable a new generative screening paradigm. Using a generated 3D protein structure as a guide, NVIDIA MolMIM generates, optimizes, and screens high-quality candidate molecules in a matter of minutes. Learn more here: build.nvidia.com/explore/healthcare

Key Points:

- BioNeMo allows us to build a virtual screening pipeline with microservices: protein folding, molecule …

bionemo compute generated generative guide medicines microservices molecules nodes nvidia nvidia bionemo paradigm protein protein structure quality screening standard virtual

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Principal Data Engineering Manager

@ Microsoft | Redmond, Washington, United States

Machine Learning Engineer

@ Apple | San Diego, California, United States